Poor 2010 outlook follows Genmab's disappointing 2009 results
This article was originally published in Scrip
Executive Summary
Genmab failed to turn its overall performance around last year as its 2009 revenues fell by 15% to DKK586 million ($113 million), following on from a 35% decline in the first nine months of the year.